Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study. [electronic resource]
Producer: 20151009Description: 1317-26 p. digitalISSN:- 1537-4505
- Adolescent
- Adult
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Hearing Loss, Sensorineural -- drug therapy
- Hearing Loss, Sudden -- drug therapy
- Humans
- Male
- Middle Aged
- Neuroprotective Agents -- administration & dosage
- Peptides -- administration & dosage
- Prospective Studies
- Tinnitus -- drug therapy
- Treatment Outcome
- Tympanic Membrane -- drug effects
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.